Internal Reference Number: FOI_7729
Date Request Received: 07/02/2024 00:00:00
Date Request Replied To: 13/02/2024 00:00:00
This response was sent via: By Email
Request Summary: Request on Migraine
Request Category: Researcher
Question Number 1: A. How many patients have been treated with the following drugs in the past 4 months: • Atogepant (Aquipta) – any disease • Erenumab (Aimovig) - any disease • Eptinezumab (Vyepti) – any disease • Fremanezumab (Ajovy) - any disease • Galcanezumab (Emgality) - any disease • Rimegepant (Vydura) – any disease • Botulinum Toxin (i.e., Botox, Dysport, Xeomin) - migraine ONLY | |
Answer To Question 1: Medication Brand name Homecare Atogepant Aquipta Not used at SFT Erenumab Aimovig Not used at SFT Eptinezumab Vyepti Not used at SFT Fremanezumab Ajovy Not used at SFT Galcanezumab Emgality Not used at SFT Botulinum All issued as stock so unable to answer. The Neurology clinic is not a service that is provided by SA¹ú¼Ê´«Ã½, the service is owned by University Hospitals Southampton NHS Foundation Trust | |
Question Number 2: See attached | |
Answer To Question 2: This is not a service that is provided by SA¹ú¼Ê´«Ã½, the service is owned by University Hospitals Southampton NHS Foundation Trust To accompany this answer to question 2 please also see the documents listed below: FOI_7729 - Q2.docx | |
Question Number 3: Does the trust actively initiate a treatment pause (usually at 12 months) of anti-CGRP (calcitonin gene-related peptide inhibitors) migraine treatment with the aim to re-start treatment if the patient continues to fit the criteria (Yes/No)? | |
Answer To Question 3: This is not a service that is provided by SA¹ú¼Ê´«Ã½, the service is owned by University Hospitals Southampton NHS Foundation Trust | |
Please see Attachments: | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.